Treating childhood acute lymphoblastic leukemia in a developing country 1998-2003: The experience of a single children's hospital in China

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 12, 2006, Pages 798-802

  Gao, Yi Jin ^a   Lu, Feng Juan ^a   Wang, Hong Sheng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Acute lymphoblastic leukemia; Childhood; Developing country; Mortality; Survival

Indexed keywords

ALLOPURINOL; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER DIAGNOSIS; CANCER RELAPSE; CHILD; CHILDHOOD LEUKEMIA; CHINA; CONTROLLED STUDY; DEATH; DEVELOPING COUNTRY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INDUSTRIALIZATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; SEPSIS; SURVIVAL RATE; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHINA; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, PEDIATRIC; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SURVIVAL RATE;

EID: 33845694058     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31802d3e7a     Document Type: Article

References (12)

1. Pavlovsky S, Sackmann Muriel F, Santarelli MT, et al. An update of the results of intensive therapy in children with acute lymphoblastic leukemia. Leukemia. 1992;6(suppl 2):167-170.
2. Campbell M, Salgado C, Quintana J, et al. Improved outcome for acute lymphoblastic leukemia in children of a developing country: results of the Chilean national trial PINDA 87. Med Pediatr Oncol. 1999;33:88-94.
3. Bonilla M, Moreno N, Marina N, et al. Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador. J Pediatr Hematol Oncol. 2000:22;495-501.
4. Laosombat V, Wongchanchailert M, Sattayasevana B, et al. The treatment of children with acute lymphoblastic leukemia in Thailand. Med Pediatr Oncol. 2002:38;266-268.
5. Magrath I, Shanta V, Advani S, et al. Treatment of acute lymphoblastic leukemia in countries with limited resourses: lessons from use of a single protocol in India over a twenty year period. Eur J Cancer. 2005;41:1570-1583.
6. Liu HC, Chen SH, Chang KH, et al. Overall and event-free survivals for acute lymphoblastic leukemia in children at a single institution in Taiwan. Pediatr Hematol Oncol. 2002;19:19-29.
7. Li CK, Chik KW, Ha SY, et al. Improved outcome of acute lymphoblastic leukaemia treated by delayed intensification in Hong Kong children: HKALL 97 study. Hong Kong Med J. 2006;12:33-39.
8. Christensen MS, Heyman M, Möttönen M, et al. Treatment-related death in childhood acute lymphoblastic leukemia in the Nordic countries: 1992-2001. Br J of Haematol. 2005;131:50-58.
9. Schrappe M, Reiter A, Ludwig W-D, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood. 2000;95:3310-3322.
10. Metzger ML, Howard SC, Fu LC, et al. Outcome of childhood acute lymphoblastic leukemia in resource-poor countries. Lancet. 2003;362:706-708.
11. Pui C-H, Ribeiro RC. International Collaboration on Childhood Leukemia. Int J Hematol. 2003;78:383-389.
12. Pui C-H, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study at St Jude Children's Research Hospital. Blood. 2004;104:2690-2696.